Device type · LXA
Tissue Graft Of 6mm And Greater
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
LXA
Cardiovascular
Device class
Class III
FDA decisions since 2015
0
510(k), De Novo and PMA
Adverse event reports
33
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Tissue Graft Of 6mm And Greater
- Product code
- LXA
- Device class
- Class III
- Review panel
- Cardiovascular
- Specialty
- Cardiology
- FDA record
- Classification database entry for LXA
Latest FDA decisions
No 510(k), De Novo or PMA decisions for this product code since 2015.
Reports received
33
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
3
9.1% of reports
Injury reports
29
88% of reports
Death reports
1
3.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 2 | 0 | 0 | 0 |
| Jan 24 | 1 | 0 | 0 | 0 |
| Feb 24 | 0 | 0 | 0 | 0 |
| Mar 24 | 0 | 0 | 0 | 0 |
| Apr 24 | 2 | 1 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 0 | 1 | 0 | 0 |
| Jul 24 | 0 | 4 | 0 | 0 |
| Aug 24 | 2 | 1 | 1 | 0 |
| Sep 24 | 0 | 0 | 1 | 0 |
| Oct 24 | 0 | 0 | 0 | 0 |
| Nov 24 | 0 | 0 | 0 | 0 |
| Dec 24 | 2 | 0 | 0 | 0 |
| Jan 25 | 0 | 0 | 0 | 0 |
| Feb 25 | 0 | 2 | 0 | 0 |
| Mar 25 | 0 | 0 | 0 | 0 |
| Apr 25 | 1 | 0 | 0 | 0 |
| May 25 | 0 | 0 | 0 | 0 |
| Jun 25 | 1 | 0 | 0 | 0 |
| Jul 25 | 3 | 0 | 0 | 0 |
| Aug 25 | 1 | 0 | 0 | 0 |
| Sep 25 | 2 | 4 | 0 | 0 |
| Oct 25 | 0 | 0 | 1 | 0 |
| Nov 25 | 0 | 6 | 0 | 0 |
| Dec 25 | 1 | 6 | 0 | 0 |
| Jan 26 | 0 | 2 | 0 | 0 |
| Feb 26 | 0 | 2 | 0 | 0 |
| Mar 26 | 0 | 0 | 0 | 0 |
| Apr 26 | 0 | 2 | 1 | 0 |
| May 26 | 0 | 1 | 0 | 0 |
| Jun 26 | 1 | 0 | 0 | 0 |
| Jul 26 | 1 | 3 | 0 | 0 |
| Aug 26 | 0 | 4 | 0 | 0 |
| Sep 26 | 0 | 2 | 0 | 0 |
| Oct 26 | 0 | 1 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Material Integrity Problem14
- Adverse Event Without Identified Device or Use Problem8
- Appropriate Device Problem Term/Code Not Available3
3 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Obstruction/Occlusion15
- Thromboembolism13
- Bacterial Infection4
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Artegraft Vascular Graft; REF#: AG740;Open, Classified
Z-1574-2026 · Started Feb 10, 2026 · Posted by FDA Mar 19, 2026
Reason given: Labeling mix-up resulting in the incorrect lot outer packaging of product.
Cause as FDA categorized it: Labeling Change Control
- Artegraft Collagen Vascular Graft; REF: AG1015;Open, Classified
Z-0289-2026 · Started Sep 25, 2025 · Posted by FDA Oct 23, 2025
Reason given: The device was incorrectly packed in the wrong size labeled outer packaging.
Cause as FDA categorized it: Packaging change control
Z-0034-2026 · Started Sep 2, 2025 · Posted by FDA Oct 2, 2025
Reason given: The bovine carotid arteries used to produce the impacted grafts from affected lots were sourced using raw material from a supplier that had not been reviewed and approved by the appropriate regulatory authority.
Cause as FDA categorized it: Nonconforming Material/Component
1 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.